Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04598074 · ClinicalTrials.gov registry record · NA
Opioid Package Prototype (OPP)
A NA study, sponsored by UConn Health.
- Not yet
- Registry status
- NA
- Development phase
- 352
- Enrollment target
NCT04598074: Clinical Trial NA study, sponsored by UConn Health.
NCT04598074 is a NA study that has not yet begun recruiting, run by UConn Health. The registered enrollment target is 352 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04598074, a NA study, has not yet begun recruiting, sponsored by UConn Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 352 participants
- Enrollment target
Study Summary
The overall objective of this clinical trial is to identify the impact of selected package features, known as the Opioid Package Prototype (OPP), on the safe and effective use of opioids. Our specific aims are: (Aim 1) to evaluate the effectiveness of OPP on prescribing, dispensing, and patient use of oxycodone among orthopaedic surgery patients receiving post-operative outpatient oxycodone for post-surgical pain management, and (Aim 2) to determine the feasibility of OPP for orthopaedic surgery prescribers, pharmacists, and orthopaedic surgery patients. Such data can be used to further optimize packaging and labeling design, help patients and caregivers utilize their medication and packaging correctly, and improve prescribing and dispensing habits. The central hypothesis is that the OPP will be more effective than the amber vial in efforts to reduce oxycodone prescribing among patients over 18 receiving short-term management of post orthopedic surgery pain.
Primary Outcome
Count via medical/pharmacy records
Interventions
- OTHER Opioid Package Prototype (OPP)
- OTHER Usual Care (standard amber vial)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 352 participants |
| Start Date | 2025-09-07 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What is known before NCT04598074 opens enrollment
NCT04598074 is an interventional study that assigns participants to a tested intervention. The registered 352 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which Opioid Package Prototype (OPP) is the first listed.
NCT04598074 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04598074 about?
NCT04598074 is a clinical study titled "Opioid Package Prototype (OPP)". The overall objective of this clinical trial is to identify the impact of selected package features, known as the Opioid Package Prototype (OPP), on the safe and effective use of opioids. Our specific aims are: (Aim 1) to evaluate the effectiveness of OPP on prescribing, dispensing, and patient use ...
What is the current status of trial NCT04598074?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 352 participants. The study started on 2025-09-07. Estimated completion is 2026-09-30.
What interventions are being tested in trial NCT04598074?
The interventions under investigation include: Opioid Package Prototype (OPP) (OTHER), Usual Care (standard amber vial) (OTHER).
Who is sponsoring clinical trial NCT04598074?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04598074's enrollment target sits among peer trials
352 292nd of 2000 higher than 1,709 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05811936 · 352 participants · NA
The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
- NCT06258941 · 352 participants · Phase 1
Classroom Break, Cognition, and Fitness in Elementary School Children
- NCT06269081 · 352 participants · NA
Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV
- NCT06337292 · 352 participants · Phase 3
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI